A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease

• Status: RECRUITING
• Trial end date: 2027-08-23

Summary

The goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease.

• Phase: PHASE2

Details

• Lead Sponsor: GlaxoSmithKline